
Obama, the Cheesecake Factory, Whole Foods and Arugula
Reporting on market developments concerning Obama, the Cheesecake Factory, Whole Foods and Arugula. Industry analysts and investors are monitoring the operational, strategic, and f...
Query our full-text historical index across market dispatches, earnings reports, central bank policies, and financial analyses.

Reporting on market developments concerning Obama, the Cheesecake Factory, Whole Foods and Arugula. Industry analysts and investors are monitoring the operational, strategic, and f...

Meritage Hospitality Group moves forward with professional advisory retentions as restaurant operators confront evolving consumer spending and labor cost realities.

Binance leadership alerts markets to an unprecedented security exploit that could mark the largest digital asset heist in financial history.

Carvana stock climbed sharply following robust vehicle sales growth and expanding unit margins, cementing investor confidence in its operational restructuring.

Burger King's modernization push and targeted value promotions are delivering results as cash-strapped consumers seek affordability in quick-service dining.

With electric vehicle adoption moderating, leading battery manufacturers are capitalizing on surging utility-scale demand driven by AI data centers and renewable integration.

Specialty running stores are leveraging competitive athletes as retail staff, driving higher conversion rates and shifting market power in the multi-billion-dollar athletic footwear sector.

Wholesale European gas contracts retreated after briefly topping €100 per megawatt-hour, offering brief respite amid persistent winter supply risks.

Campari shares dropped sharply after the Italian spirits maker warned that intensifying competition and logistics bottlenecks in the crucial U.S. market are dampening growth.

Shell shares rallied strongly after the global energy giant reported a sharp doubling of quarterly earnings, driven by resilient gas trading and disciplined capital allocation.

Bristol Myers Squibb has raised its annual financial outlook following stronger-than-expected quarterly revenue, driven by robust uptake in its growth portfolio.

Eli Lilly posted significant revenue gains driven by unprecedented global demand for its blockbuster treatments Mounjaro and Zepbound, solidifying its leadership in the metabolic therapeutics market.